-
SOURCES OF BIAS IN PATIENT-REPORTED OUTCOME (PRO) DATA COLLECTION: EVIDENCE GAPS IN THEIR IMPACT ON DATA QUALITY
Mar 18, 2026, 21:38 PM -
MODELING THE LIFETIME BENEFITS OF ETEPLIRSEN IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Mar 18, 2026, 21:38 PM -
ASSESSING DISTRIBUTION OF SOCIAL AND PRIVATE VALUE CREATION BY DRUGS REGULATING PROGRAMMED CELL DEATH-1IN CANCER TREATMENT...
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A COMPOSITE ENDPOINT IN HYPOPHOSPHATASIA TO OPTIMIZE COST-EFFECTIVENESS DEMONSTRATION
Mar 18, 2026, 21:38 PM -
HOW IMPROVING SCHOOL-AGED CHILDREN’S HEALTH CAN SIMULTANEOUSLY REDUCE INEQUALITY IN BOTH HEALTH AND WEALTH
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING TO DIFFERENTIATE CONGESTIVE HEART FAILURE ONSET AMONG HIGH-RISK PATIENTS IDENTIFIED BY THE FRAMINGHAM RISK SCORE
Mar 18, 2026, 21:38 PM -
PATIENT DEMOGRAPHICS AND BASELINE CLINICAL CHARACTERISTICS IN GASTROESOPHAGEAL REFLUX DISEASE BY VONOPRAZAN TREATMENT DURATION: RESULTS FROM A POST-HOC ANALYSIS OF THE VIEW STUDY
Mar 18, 2026, 21:38 PM -
UNDERSTANDING CEA CHARACTERISTICS ASSOCIATED WITH COST-SAVING FINDINGS
Mar 18, 2026, 21:38 PM -
GENAI FOR NEXT-GENERATION JCA WORKFLOWS: AUTOMATING EVIDENCE GENERATION WHILE ENSURING TRANSPARENT, TRACEABLE EU-HTA SUBMISSIONS
Mar 18, 2026, 21:38 PM -
TITLE: COST-UTILITY ANALYSIS OF CALCITONIN GENE-RELATED PEPTIDE ANTIBODIES FOR PATIENTS WITH CHRONIC MIGRAINE: A UNITED STATES PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
ADVANCING COMPUTABLE OPERATIONAL DEFINITIONS WITH ONTOLOGY MAPPING AND SYNTHETIC DATA SIMULATION FOR MORE CONSISTENT REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF AN ALGORITHM TO IDENTIFY ASPIRIN USE FROM ELECTRONIC MEDICAL RECORDS AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
LABORATORY MARKERS AND SHORT-TERM OUTCOMES IN RESPIRATORY SYNCYTIAL VIRUS AMONG OLDER ADULTS: MEDICARE-ENHANCED AND LABORATORY DATA ANALYSIS 2021-2025
Mar 18, 2026, 21:38 PM -
REAL-WORLD OUTCOMES OF MECHANICAL, PORCINE, AND DURABLE VALVES IN SEVERE AORTIC STENOSIS: SURVIVAL, REINTERVENTION, AND EARLY MORTALITY ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF VASOMOTOR SYMPTOMS AND DEPRESSION ON HEALTHCARE EXPENDITURES AMONG U.S. WOMEN
Mar 18, 2026, 21:38 PM -
US MEDICINE PRICING POLICY CHANGES: IMPACT ON THE FULL BIOPHARMACEUTICAL INVESTMENT ECOSYSTEM
Mar 18, 2026, 21:38 PM -
HOSPITAL BUDGET IMPACT MODEL OF TV-46000, A LONG-ACTING SUBCUTANEOUS FORMULATION OF RISPERIDONE, VERSUS ONCE-MONTHLY PALIPERIDONE PALMITATE IN ADULTS WITH SCHIZOPHRENIA IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
EARLY IDENTIFICATION AND MANAGEMENT OF POST-CARDIAC SURGERY COMPLICATIONS: IMPLICATIONS FOR CLINICAL PRACTICE, CARDIO-ONCOLOGY, AND HEALTH ECONOMICS
Mar 18, 2026, 21:38 PM
